Senior Principal Scientist/Director
AbbVie Inc.
Libertyville, Illinois
Dr. Ju is recognized for his in-depth knowledge and technical experiences in both formulation and dissolution method development, as his teams were directly responsible for the formulation development of 7 NDAs, dissolution method development of 8 NDAs/Phase III projects, including oral biologics and implants. At Abbvie, he established the Drug Release and Product Performance group with focuses on in-silico modelling, images and functional excipient release, and cross-functional alignment. He advocates in vitro release method development based on formulation design and release mechanisms. Extensive interactions with global regulators on biowaiver, IVIVC, PBPK/PBBM modelling, and discrimination. Recognized expertise in biopharmaceutics, modified release formulations, pediatric formulations, amorphous solid dispersion, and FDC technologies for challenging molecules. Patents filings and litigation. Experiences with long acting injectables, oral peptides, and eye care products (implants and eye drops). Dr. Ju founded the Pediatric Working Group and chaired the Drug Product Leadership Group of IQ Consortium. He was inducted into the prestigious Vowiler Society within AbbVie, sat in the Scientific and Education Board of NIPTE, and was an Adjunct Professor of Roosevelt University. In leisure time, Rob enjoys coaching sport teams, working out in the gym, cycling, cooking and gardening.
Disclosure information not submitted.
Advances in Computational Analysis of Dissolution - ASD
Wednesday, November 12, 2025
10:00 AM - 10:30 AM CT